Global Atrial Fibrillation Surgery Market
Global Atrial Fibrillation Surgery Market

Atrial Fibrillation Surgery Comprehensive Study by Type (Ablation Surgeries, - Radiofrequency Ablation, - Sonar, - Microwave, - Cryoablation, Atrioventricular Node Ablation, Maze Procedure), Application (Mitral Stenosis, Hyperthyroidism, High Blood Pressure, Pulmonary Embolus, Pneumonia) Players and Region - Global Market Outlook to 2024

Atrial Fibrillation Surgery Market Segmented into XX Submarkets. | Forecast Years: 2019- 2024  

May 2019 Edition 237 Pages 200 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Industry Background:
Atrial fibrillation is a condition involves abnormal heartbeat. There are different types of surgeries used to treat atrial fibrillation. There is the development of atrial fibrillation ablation technologies which aims for reducing the need for repeat procedures and to reduce procedure times. There are different treatment options for managing A-fib, including lifestyle changes, medications, and other nonsurgical options. While these treatments may help some people, they may not work for everybody and are not a cure. Doctors may consider surgery if a patient's medications aren't working and when nothing else has helped.This growth is primarily driven by Rise in Generality of Atrial Fibrillation in Geriatric Population and Technology Advancement.

Globally, a noticeable market trend is evident High Preference of Catheter Ablation for Cardiac Arrhythmia Treatment. Major Players, such as Biosense Webster Inc. (United States), Medtronic plc (Ireland), Abbott Laboratories (United States), Boston Scientific Corporation (United States), AtriCure Inc. (United States), Biotronik SE & Co. KG (Germany), Cardiofocus Inc. (United States) and Johnsons & Johnson Ltd (United States) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

In Jan 2019, Abbott Announced United States Food And Drug Administration (FDA) Approval Of The Tacticath Contact Force Ablation Catheter Sensor Enabled, A New Ablation Catheter Designed To Help Physicians Accurately And Effectively Treat Atrial Fibrillation. Additionally In Jan 2019 Nebraska Medicine Disclosed a Study Which Define New Surgical Procedure Improves Outcomes for Most Advanced Atrial Fibrillation Cases

Market Drivers
  • Rise in Generality of Atrial Fibrillation in Geriatric Population
  • Technology Advancement

Market Trend
  • High Preference of Catheter Ablation for Cardiac Arrhythmia Treatment

Restraints
  • Unfavourable Preference for Pharmaceutical Interventions (Drugs) Over Atrial Fibrillation Surgeries Is Hamper the Growth of the Market


Challenges
Some Side Effects Include Mild Pain, Bleeding, Bruising, Vein Problems

AdvanceMarketAnalytics follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.

Customization of the Report:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Type
  • Ablation Surgeries
  • - Radiofrequency Ablation
  • - Sonar
  • - Microwave
  • - Cryoablation
  • Atrioventricular Node Ablation
  • Maze Procedure
By Application
  • Mitral Stenosis
  • Hyperthyroidism
  • High Blood Pressure
  • Pulmonary Embolus
  • Pneumonia
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rise in Generality of Atrial Fibrillation in Geriatric Population
      • 3.2.2. Technology Advancement
    • 3.3. Market Challenges
      • 3.3.1. Some Side Effects Include Mild Pain, Bleeding, Bruising, Vein Problems
    • 3.4. Market Trends
      • 3.4.1. High Preference of Catheter Ablation for Cardiac Arrhythmia Treatment
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Atrial Fibrillation Surgery, by Type, Application and Region (value) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Atrial Fibrillation Surgery (Value)
      • 5.2.1. Global Atrial Fibrillation Surgery by: Type (Value)
        • 5.2.1.1. Ablation Surgeries
        • 5.2.1.2. - Radiofrequency Ablation
        • 5.2.1.3. - Sonar
        • 5.2.1.4. - Microwave
        • 5.2.1.5. - Cryoablation
        • 5.2.1.6. Atrioventricular Node Ablation
        • 5.2.1.7. Maze Procedure
      • 5.2.2. Global Atrial Fibrillation Surgery by: Application (Value)
        • 5.2.2.1. Mitral Stenosis
        • 5.2.2.2. Hyperthyroidism
        • 5.2.2.3. High Blood Pressure
        • 5.2.2.4. Pulmonary Embolus
        • 5.2.2.5. Pneumonia
      • 5.2.3. Global Atrial Fibrillation Surgery Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Atrial Fibrillation Surgery: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Biosense Webster Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Medtronic plc (Ireland)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Abbott Laboratories (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Boston Scientific Corporation (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. AtriCure Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Biotronik SE & Co. KG (Germany)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Cardiofocus Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Johnsons & Johnson Ltd (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
  • 7. Global Atrial Fibrillation Surgery Sale, by Type, Application and Region (value) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Atrial Fibrillation Surgery (Value)
      • 7.2.1. Global Atrial Fibrillation Surgery by: Type (Value)
        • 7.2.1.1. Ablation Surgeries
        • 7.2.1.2. - Radiofrequency Ablation
        • 7.2.1.3. - Sonar
        • 7.2.1.4. - Microwave
        • 7.2.1.5. - Cryoablation
        • 7.2.1.6. Atrioventricular Node Ablation
        • 7.2.1.7. Maze Procedure
      • 7.2.2. Global Atrial Fibrillation Surgery by: Application (Value)
        • 7.2.2.1. Mitral Stenosis
        • 7.2.2.2. Hyperthyroidism
        • 7.2.2.3. High Blood Pressure
        • 7.2.2.4. Pulmonary Embolus
        • 7.2.2.5. Pneumonia
      • 7.2.3. Global Atrial Fibrillation Surgery Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Atrial Fibrillation Surgery: by Type(USD Million)
  • Table 2. Atrial Fibrillation Surgery Ablation Surgeries , by Region USD Million (2013-2018)
  • Table 3. Atrial Fibrillation Surgery - Radiofrequency Ablation , by Region USD Million (2013-2018)
  • Table 4. Atrial Fibrillation Surgery - Sonar , by Region USD Million (2013-2018)
  • Table 5. Atrial Fibrillation Surgery - Microwave , by Region USD Million (2013-2018)
  • Table 6. Atrial Fibrillation Surgery - Cryoablation , by Region USD Million (2013-2018)
  • Table 7. Atrial Fibrillation Surgery Atrioventricular Node Ablation , by Region USD Million (2013-2018)
  • Table 8. Atrial Fibrillation Surgery Maze Procedure , by Region USD Million (2013-2018)
  • Table 9. Atrial Fibrillation Surgery: by Application(USD Million)
  • Table 10. Atrial Fibrillation Surgery Mitral Stenosis , by Region USD Million (2013-2018)
  • Table 11. Atrial Fibrillation Surgery Hyperthyroidism , by Region USD Million (2013-2018)
  • Table 12. Atrial Fibrillation Surgery High Blood Pressure , by Region USD Million (2013-2018)
  • Table 13. Atrial Fibrillation Surgery Pulmonary Embolus , by Region USD Million (2013-2018)
  • Table 14. Atrial Fibrillation Surgery Pneumonia , by Region USD Million (2013-2018)
  • Table 15. South America Atrial Fibrillation Surgery, by Country USD Million (2013-2018)
  • Table 16. South America Atrial Fibrillation Surgery, by Type USD Million (2013-2018)
  • Table 17. South America Atrial Fibrillation Surgery, by Application USD Million (2013-2018)
  • Table 18. Brazil Atrial Fibrillation Surgery, by Type USD Million (2013-2018)
  • Table 19. Brazil Atrial Fibrillation Surgery, by Application USD Million (2013-2018)
  • Table 20. Argentina Atrial Fibrillation Surgery, by Type USD Million (2013-2018)
  • Table 21. Argentina Atrial Fibrillation Surgery, by Application USD Million (2013-2018)
  • Table 22. Rest of South America Atrial Fibrillation Surgery, by Type USD Million (2013-2018)
  • Table 23. Rest of South America Atrial Fibrillation Surgery, by Application USD Million (2013-2018)
  • Table 24. Asia Pacific Atrial Fibrillation Surgery, by Country USD Million (2013-2018)
  • Table 25. Asia Pacific Atrial Fibrillation Surgery, by Type USD Million (2013-2018)
  • Table 26. Asia Pacific Atrial Fibrillation Surgery, by Application USD Million (2013-2018)
  • Table 27. China Atrial Fibrillation Surgery, by Type USD Million (2013-2018)
  • Table 28. China Atrial Fibrillation Surgery, by Application USD Million (2013-2018)
  • Table 29. Japan Atrial Fibrillation Surgery, by Type USD Million (2013-2018)
  • Table 30. Japan Atrial Fibrillation Surgery, by Application USD Million (2013-2018)
  • Table 31. India Atrial Fibrillation Surgery, by Type USD Million (2013-2018)
  • Table 32. India Atrial Fibrillation Surgery, by Application USD Million (2013-2018)
  • Table 33. South Korea Atrial Fibrillation Surgery, by Type USD Million (2013-2018)
  • Table 34. South Korea Atrial Fibrillation Surgery, by Application USD Million (2013-2018)
  • Table 35. Taiwan Atrial Fibrillation Surgery, by Type USD Million (2013-2018)
  • Table 36. Taiwan Atrial Fibrillation Surgery, by Application USD Million (2013-2018)
  • Table 37. Australia Atrial Fibrillation Surgery, by Type USD Million (2013-2018)
  • Table 38. Australia Atrial Fibrillation Surgery, by Application USD Million (2013-2018)
  • Table 39. Rest of Asia-Pacific Atrial Fibrillation Surgery, by Type USD Million (2013-2018)
  • Table 40. Rest of Asia-Pacific Atrial Fibrillation Surgery, by Application USD Million (2013-2018)
  • Table 41. Europe Atrial Fibrillation Surgery, by Country USD Million (2013-2018)
  • Table 42. Europe Atrial Fibrillation Surgery, by Type USD Million (2013-2018)
  • Table 43. Europe Atrial Fibrillation Surgery, by Application USD Million (2013-2018)
  • Table 44. Germany Atrial Fibrillation Surgery, by Type USD Million (2013-2018)
  • Table 45. Germany Atrial Fibrillation Surgery, by Application USD Million (2013-2018)
  • Table 46. France Atrial Fibrillation Surgery, by Type USD Million (2013-2018)
  • Table 47. France Atrial Fibrillation Surgery, by Application USD Million (2013-2018)
  • Table 48. Italy Atrial Fibrillation Surgery, by Type USD Million (2013-2018)
  • Table 49. Italy Atrial Fibrillation Surgery, by Application USD Million (2013-2018)
  • Table 50. United Kingdom Atrial Fibrillation Surgery, by Type USD Million (2013-2018)
  • Table 51. United Kingdom Atrial Fibrillation Surgery, by Application USD Million (2013-2018)
  • Table 52. Netherlands Atrial Fibrillation Surgery, by Type USD Million (2013-2018)
  • Table 53. Netherlands Atrial Fibrillation Surgery, by Application USD Million (2013-2018)
  • Table 54. Rest of Europe Atrial Fibrillation Surgery, by Type USD Million (2013-2018)
  • Table 55. Rest of Europe Atrial Fibrillation Surgery, by Application USD Million (2013-2018)
  • Table 56. MEA Atrial Fibrillation Surgery, by Country USD Million (2013-2018)
  • Table 57. MEA Atrial Fibrillation Surgery, by Type USD Million (2013-2018)
  • Table 58. MEA Atrial Fibrillation Surgery, by Application USD Million (2013-2018)
  • Table 59. Middle East Atrial Fibrillation Surgery, by Type USD Million (2013-2018)
  • Table 60. Middle East Atrial Fibrillation Surgery, by Application USD Million (2013-2018)
  • Table 61. Africa Atrial Fibrillation Surgery, by Type USD Million (2013-2018)
  • Table 62. Africa Atrial Fibrillation Surgery, by Application USD Million (2013-2018)
  • Table 63. North America Atrial Fibrillation Surgery, by Country USD Million (2013-2018)
  • Table 64. North America Atrial Fibrillation Surgery, by Type USD Million (2013-2018)
  • Table 65. North America Atrial Fibrillation Surgery, by Application USD Million (2013-2018)
  • Table 66. United States Atrial Fibrillation Surgery, by Type USD Million (2013-2018)
  • Table 67. United States Atrial Fibrillation Surgery, by Application USD Million (2013-2018)
  • Table 68. Canada Atrial Fibrillation Surgery, by Type USD Million (2013-2018)
  • Table 69. Canada Atrial Fibrillation Surgery, by Application USD Million (2013-2018)
  • Table 70. Mexico Atrial Fibrillation Surgery, by Type USD Million (2013-2018)
  • Table 71. Mexico Atrial Fibrillation Surgery, by Application USD Million (2013-2018)
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Company Basic Information, Sales Area and Its Competitors
  • Table 76. Company Basic Information, Sales Area and Its Competitors
  • Table 77. Company Basic Information, Sales Area and Its Competitors
  • Table 78. Company Basic Information, Sales Area and Its Competitors
  • Table 79. Company Basic Information, Sales Area and Its Competitors
  • Table 80. Atrial Fibrillation Surgery: by Type(USD Million)
  • Table 81. Atrial Fibrillation Surgery Ablation Surgeries , by Region USD Million (2019-2024)
  • Table 82. Atrial Fibrillation Surgery - Radiofrequency Ablation , by Region USD Million (2019-2024)
  • Table 83. Atrial Fibrillation Surgery - Sonar , by Region USD Million (2019-2024)
  • Table 84. Atrial Fibrillation Surgery - Microwave , by Region USD Million (2019-2024)
  • Table 85. Atrial Fibrillation Surgery - Cryoablation , by Region USD Million (2019-2024)
  • Table 86. Atrial Fibrillation Surgery Atrioventricular Node Ablation , by Region USD Million (2019-2024)
  • Table 87. Atrial Fibrillation Surgery Maze Procedure , by Region USD Million (2019-2024)
  • Table 88. Atrial Fibrillation Surgery: by Application(USD Million)
  • Table 89. Atrial Fibrillation Surgery Mitral Stenosis , by Region USD Million (2019-2024)
  • Table 90. Atrial Fibrillation Surgery Hyperthyroidism , by Region USD Million (2019-2024)
  • Table 91. Atrial Fibrillation Surgery High Blood Pressure , by Region USD Million (2019-2024)
  • Table 92. Atrial Fibrillation Surgery Pulmonary Embolus , by Region USD Million (2019-2024)
  • Table 93. Atrial Fibrillation Surgery Pneumonia , by Region USD Million (2019-2024)
  • Table 94. South America Atrial Fibrillation Surgery, by Country USD Million (2019-2024)
  • Table 95. South America Atrial Fibrillation Surgery, by Type USD Million (2019-2024)
  • Table 96. South America Atrial Fibrillation Surgery, by Application USD Million (2019-2024)
  • Table 97. Brazil Atrial Fibrillation Surgery, by Type USD Million (2019-2024)
  • Table 98. Brazil Atrial Fibrillation Surgery, by Application USD Million (2019-2024)
  • Table 99. Argentina Atrial Fibrillation Surgery, by Type USD Million (2019-2024)
  • Table 100. Argentina Atrial Fibrillation Surgery, by Application USD Million (2019-2024)
  • Table 101. Rest of South America Atrial Fibrillation Surgery, by Type USD Million (2019-2024)
  • Table 102. Rest of South America Atrial Fibrillation Surgery, by Application USD Million (2019-2024)
  • Table 103. Asia Pacific Atrial Fibrillation Surgery, by Country USD Million (2019-2024)
  • Table 104. Asia Pacific Atrial Fibrillation Surgery, by Type USD Million (2019-2024)
  • Table 105. Asia Pacific Atrial Fibrillation Surgery, by Application USD Million (2019-2024)
  • Table 106. China Atrial Fibrillation Surgery, by Type USD Million (2019-2024)
  • Table 107. China Atrial Fibrillation Surgery, by Application USD Million (2019-2024)
  • Table 108. Japan Atrial Fibrillation Surgery, by Type USD Million (2019-2024)
  • Table 109. Japan Atrial Fibrillation Surgery, by Application USD Million (2019-2024)
  • Table 110. India Atrial Fibrillation Surgery, by Type USD Million (2019-2024)
  • Table 111. India Atrial Fibrillation Surgery, by Application USD Million (2019-2024)
  • Table 112. South Korea Atrial Fibrillation Surgery, by Type USD Million (2019-2024)
  • Table 113. South Korea Atrial Fibrillation Surgery, by Application USD Million (2019-2024)
  • Table 114. Taiwan Atrial Fibrillation Surgery, by Type USD Million (2019-2024)
  • Table 115. Taiwan Atrial Fibrillation Surgery, by Application USD Million (2019-2024)
  • Table 116. Australia Atrial Fibrillation Surgery, by Type USD Million (2019-2024)
  • Table 117. Australia Atrial Fibrillation Surgery, by Application USD Million (2019-2024)
  • Table 118. Rest of Asia-Pacific Atrial Fibrillation Surgery, by Type USD Million (2019-2024)
  • Table 119. Rest of Asia-Pacific Atrial Fibrillation Surgery, by Application USD Million (2019-2024)
  • Table 120. Europe Atrial Fibrillation Surgery, by Country USD Million (2019-2024)
  • Table 121. Europe Atrial Fibrillation Surgery, by Type USD Million (2019-2024)
  • Table 122. Europe Atrial Fibrillation Surgery, by Application USD Million (2019-2024)
  • Table 123. Germany Atrial Fibrillation Surgery, by Type USD Million (2019-2024)
  • Table 124. Germany Atrial Fibrillation Surgery, by Application USD Million (2019-2024)
  • Table 125. France Atrial Fibrillation Surgery, by Type USD Million (2019-2024)
  • Table 126. France Atrial Fibrillation Surgery, by Application USD Million (2019-2024)
  • Table 127. Italy Atrial Fibrillation Surgery, by Type USD Million (2019-2024)
  • Table 128. Italy Atrial Fibrillation Surgery, by Application USD Million (2019-2024)
  • Table 129. United Kingdom Atrial Fibrillation Surgery, by Type USD Million (2019-2024)
  • Table 130. United Kingdom Atrial Fibrillation Surgery, by Application USD Million (2019-2024)
  • Table 131. Netherlands Atrial Fibrillation Surgery, by Type USD Million (2019-2024)
  • Table 132. Netherlands Atrial Fibrillation Surgery, by Application USD Million (2019-2024)
  • Table 133. Rest of Europe Atrial Fibrillation Surgery, by Type USD Million (2019-2024)
  • Table 134. Rest of Europe Atrial Fibrillation Surgery, by Application USD Million (2019-2024)
  • Table 135. MEA Atrial Fibrillation Surgery, by Country USD Million (2019-2024)
  • Table 136. MEA Atrial Fibrillation Surgery, by Type USD Million (2019-2024)
  • Table 137. MEA Atrial Fibrillation Surgery, by Application USD Million (2019-2024)
  • Table 138. Middle East Atrial Fibrillation Surgery, by Type USD Million (2019-2024)
  • Table 139. Middle East Atrial Fibrillation Surgery, by Application USD Million (2019-2024)
  • Table 140. Africa Atrial Fibrillation Surgery, by Type USD Million (2019-2024)
  • Table 141. Africa Atrial Fibrillation Surgery, by Application USD Million (2019-2024)
  • Table 142. North America Atrial Fibrillation Surgery, by Country USD Million (2019-2024)
  • Table 143. North America Atrial Fibrillation Surgery, by Type USD Million (2019-2024)
  • Table 144. North America Atrial Fibrillation Surgery, by Application USD Million (2019-2024)
  • Table 145. United States Atrial Fibrillation Surgery, by Type USD Million (2019-2024)
  • Table 146. United States Atrial Fibrillation Surgery, by Application USD Million (2019-2024)
  • Table 147. Canada Atrial Fibrillation Surgery, by Type USD Million (2019-2024)
  • Table 148. Canada Atrial Fibrillation Surgery, by Application USD Million (2019-2024)
  • Table 149. Mexico Atrial Fibrillation Surgery, by Type USD Million (2019-2024)
  • Table 150. Mexico Atrial Fibrillation Surgery, by Application USD Million (2019-2024)
  • Table 151. Research Programs/Design for This Report
  • Table 152. Key Data Information from Secondary Sources
  • Table 153. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Atrial Fibrillation Surgery: by Type USD Million (2013-2018)
  • Figure 5. Global Atrial Fibrillation Surgery: by Application USD Million (2013-2018)
  • Figure 6. South America Atrial Fibrillation Surgery Share (%), by Country
  • Figure 7. Asia Pacific Atrial Fibrillation Surgery Share (%), by Country
  • Figure 8. Europe Atrial Fibrillation Surgery Share (%), by Country
  • Figure 9. MEA Atrial Fibrillation Surgery Share (%), by Country
  • Figure 10. North America Atrial Fibrillation Surgery Share (%), by Country
  • Figure 11. Global Atrial Fibrillation Surgery share by Players 2018 (%)
  • Figure 12. Global Atrial Fibrillation Surgery share by Players (Top 3) 2018(%)
  • Figure 13. Global Atrial Fibrillation Surgery share by Players (Top 5) 2018(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Biosense Webster Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 16. Biosense Webster Inc. (United States) Revenue: by Geography 2018
  • Figure 17. Medtronic plc (Ireland) Revenue, Net Income and Gross profit
  • Figure 18. Medtronic plc (Ireland) Revenue: by Geography 2018
  • Figure 19. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 20. Abbott Laboratories (United States) Revenue: by Geography 2018
  • Figure 21. Boston Scientific Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 22. Boston Scientific Corporation (United States) Revenue: by Geography 2018
  • Figure 23. AtriCure Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 24. AtriCure Inc. (United States) Revenue: by Geography 2018
  • Figure 25. Biotronik SE & Co. KG (Germany) Revenue, Net Income and Gross profit
  • Figure 26. Biotronik SE & Co. KG (Germany) Revenue: by Geography 2018
  • Figure 27. Cardiofocus Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 28. Cardiofocus Inc. (United States) Revenue: by Geography 2018
  • Figure 29. Johnsons & Johnson Ltd (United States) Revenue, Net Income and Gross profit
  • Figure 30. Johnsons & Johnson Ltd (United States) Revenue: by Geography 2018
  • Figure 31. Global Atrial Fibrillation Surgery: by Type USD Million (2019-2024)
  • Figure 32. Global Atrial Fibrillation Surgery: by Application USD Million (2019-2024)
  • Figure 33. South America Atrial Fibrillation Surgery Share (%), by Country
  • Figure 34. Asia Pacific Atrial Fibrillation Surgery Share (%), by Country
  • Figure 35. Europe Atrial Fibrillation Surgery Share (%), by Country
  • Figure 36. MEA Atrial Fibrillation Surgery Share (%), by Country
  • Figure 37. North America Atrial Fibrillation Surgery Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Biosense Webster Inc. (United States)
  • Medtronic plc (Ireland)
  • Abbott Laboratories (United States)
  • Boston Scientific Corporation (United States)
  • AtriCure Inc. (United States)
  • Biotronik SE & Co. KG (Germany)
  • Cardiofocus Inc. (United States)
  • Johnsons & Johnson Ltd (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation